Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
10/2008
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255028 Collagen Receptor I-Domain Binding Modulators
10/16/2008DE102008010534A1 Neuartige Phosphonium-Basierte ionische Flüssigkeit sowie diese verwendendes Reaktionslösungsmittel Novel phosphonium-based ionic liquid-use and this reaction solvent
10/16/2008DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/16/2008CA2683557A1 Inhibitors of histone deacetylase
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1979361A2 Oxonium and sulfonium salts
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1308436B1 Calcium receptor antagonists
10/15/2008CN101287718A Substituted heteroaryl- and phenylsulfamoyl compounds
10/15/2008CN101287702A N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284807A Preparation method of tamsulosin
10/15/2008CN101284773A Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
10/14/2008US7435815 Sulfonylamino-acetic acid derivatives
10/09/2008WO2008119773A1 Amide derivatives as inhibitors of aspartyl proteases
10/09/2008WO2008119772A1 Amide derivatives as inhibitors of aspartyl proteases
10/09/2008US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases
10/08/2008EP1697316B1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation
10/08/2008CN101282940A Fluorinated compounds
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques
10/07/2008US7432302 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
10/02/2008WO2008074755A3 Novel cinnamic amide derivatives useful as ion channel modulators
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008US20080242643 4-[({[4,5-bis(nitrooxy)pentyl]oxy}carbonyl)oxy]-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoic acid; antiinflammatory, analgesic agent; rheumatic diseases, influenza, common cold, pain, dysmenorrhea, headache, neuralgia, synovitis, arthritis, osteoarthritis, cardiovascular disorders, anticoagulants
10/02/2008DE102007015169A1 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases
10/01/2008EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof
10/01/2008EP1973537A1 Carbamate antibiotics
10/01/2008CN100422147C Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
10/01/2008CN100422145C Method of preparing sulfone amide and method of using said sulfone smine to prepare N-substituted imine
09/2008
09/30/2008US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS
09/30/2008CA2303848C Substituted anilides
09/25/2008WO2008114831A1 Antibacterial agent having sulfonamide group
09/25/2008WO2008114022A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
09/25/2008WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
09/25/2008WO2008113756A2 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
09/25/2008US20080234491 Process for preparation of celecoxib
09/25/2008US20080234383 Novel Compounds, Isomer Thereof, or Pharmaceutically Acceptable Salts Thereof as Vanilloid Receptor Antagonist; and Pharmaceutical Compositions Containing the Same
09/25/2008CA2681320A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents
09/25/2008CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
09/25/2008CA2680239A1 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
09/24/2008EP1972617A1 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/18/2008WO2008110698A2 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
09/18/2008WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008US20080227995 Process of Sulfonating 4-Aminobenzonitriles
09/18/2008US20080227858 as collagenase 1, 2 and 3, gelatinase A and B, stromelysin 1, 2 and 3, matrilysin, macrophage metalloelastase, enamelysin and membrane type 1, 2, 3 and 4 MMP; [(4'-Cyano-1,1'-biphenyl-4-yl)(methylsulfonyl)amino]acetic acid; antiinflammatory, anticarcinogenic agent, neurodegenerative diseases
09/18/2008US20080227684 Small Molecule Inhibitors of PDZ Interactions
09/18/2008CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008CA2677295A1 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof
09/17/2008EP1968966A1 Inhibitors of ccr9 activity
09/17/2008CN101268042A Styrylsulfonamides, their manufacture and use as pharmaceutical agents
09/17/2008CN101268041A Sulphonamide derivatives
09/16/2008US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
09/16/2008US7425631 Compounds and methods of use
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/12/2008WO2008107661A1 New methylenebisphenyl compounds useful in the treatment of inflammation
09/12/2008WO2008107176A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
09/12/2008CA2680139A1 New methylenebisphenyl compounds useful in the treatment of inflammation
09/11/2008US20080221169 3-carboxy aryl sulfonamide compounds, which agonize or antagonize aquaporin channels; brain trauma, head trauma, eye disorder, pulmonary disorder, lung disease, vascular disease, kidney disease, heavy metal toxicity, Alzheimer's disease, tumor, and cancer
09/11/2008US20080220371 disulfoneamines as acid generators capable of generating an acid upon irradiation with actinic ray or radiation; use in making semiconductors, printed circuits; improve Post Exposure Bake temperature dependency and exposure latitude
09/10/2008EP1966131A1 Inhibitors of ccr9 activity
09/10/2008EP1965785A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor
09/10/2008EP1301474B1 Tyrosine derivatives as phosphatase inhibitors
09/10/2008CN101260073A Quasi-peptides HIV-1 protease inhibitor, preparation method and use
09/10/2008CN101260069A Method for preparing nimesulide intermediate 2-phenoxymethanesulphonylaniline
09/10/2008CN100417643C Method for extracting dihydro-quercetin from larch
09/09/2008US7423181 Aminoalkoxy-functional chalcones
09/09/2008US7423164 Synthesis of ionic liquids
09/09/2008US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
09/09/2008US7423035 e.g. 5-hydroxy-8-{1-hydroxy-2-[1-(4-methoxy-benzyl)-cyclopropylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity
09/04/2008WO2008105386A1 Rexinoid compound having alkoxy group
09/04/2008US20080214870 Method of Preparing Amine Stereoisomers
09/04/2008US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist
09/04/2008US20080213698 Novel Colorant Compound and Method of Manufacturing the Same as Well as Blue Resist Composition for Use in Color Filter Containing the Same
09/03/2008EP1963277A1 Fluorinated compounds
09/03/2008EP1963259A2 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
09/03/2008EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008US7419974 Cyclohexyl(alkyl)propanolamines, preparation method and pharmaceutical compositions containing same
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
09/02/2008CA2169696C Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
08/2008
08/28/2008WO2008102908A1 Haloalkylsulfonanilide derivative
08/28/2008WO2008101810A1 Use of urea derivatives in washing and cleaning compositions
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080207689 Formamide Derivatives For The Treatment of Diseases
08/28/2008US20080207584 Compound Having S1P Receptor Binding Potency and Use Thereof
08/27/2008EP1960343A2 Indene derivatives, their preparation and use as medicaments
08/27/2008EP1799636B1 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
08/27/2008EP1581474B1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
08/27/2008EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/27/2008CN100413848C Acylsulfamoyl benzoic acid amides, plant protection agents containing same, and method for producing same
08/27/2008CN100413844C Multiple photon absorptive phenyl fluorene derivative and its preparing method
08/26/2008US7417169 Amino alcohol derivatives, medicinal composition containing the same, and use of these
08/26/2008US7417164 Fluorescent dyes, including 8-hydroxypyrene-1,3,6-trislfonic acid (HPTS) and its derivatives; useful for analyte detection, determining blood glucose concentration
08/26/2008US7417060 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 177